We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanoparticles Heated by Radio Waves Kill Cells by Destroying Their DNA

By LabMedica International staff writers
Posted on 04 Nov 2008
Print article
A recent publication described the use of graphitic carbon-coated ferromagnetic cobalt nanoparticles to kill cells growing in tissue culture, which is the first step toward adapting the technique to destroy cancer cells in humans.

Investigators at the University of Arkansas (Little Rock, USA) used a catalytic chemical vapor deposition technique to synthesize cubic crystalline graphitic carbon-coated ferromagnetic cobalt nanoparticles (C–Co-NPs) with diameters of around seven nanometers. They used X-ray diffraction and X-ray photoelectron spectroscopy analysis to show that the cobalt nanoparticles inside the carbon shells were preserved in the metallic state. Then, they used fluorescence microscopy images and Raman spectroscopy to demonstrate that the nanoparticles effectively penetrated the cellular plasma membrane of cultured HeLa cells, both inside the cytoplasm and in the nucleus.

Data published in the October 29, 2008, issue of the journal Nanotechnology, revealed that low radio frequency (RF) radiation of 350 kHz induced localized heat into the metallic nanoparticles, which triggered the killing of the HeLa cells, a process that was found to be dependent on the RF application time and nanoparticle concentration. DNA gel electrophoresis assays of the HeLa cells after the RF treatment showed massive DNA fragmentation, which proved that the localized application of heat induced DNA damage and nucleus membrane disintegration.

"We have demonstrated that using a combination of a low frequency, low power radio frequency radiation – which has a high penetration ability in human tissue – with graphitic-magnetic composite nanoparticles could prove an excellent means of raising the temperature at the cellular level above the threshold required for DNA fragmentation or protein denaturation,” said senior author Dr. Alexandru Biris, assistant professor of applied science at the University of Arkansas. "The result is death of the cells. This technique is less invasive and possesses higher efficiency for targeting localized cells. It also has the potential to reduce the side effects associated with traditional cancer therapies.”

Related Links:
University of Arkansas


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Centromere B Assay
Centromere B Test

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The test monitors blood levels of DNA fragments released by dying tumor cells (Photo courtesy of 123RF)

Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer

Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.